EUVIMEDEUVIMED entdecken
Crossref

YAP plays a critical role in myocardial recovery from myocarditis by suppressing IFN-γ signalling pathway

Yusuke Kametani, Masanori Obana, Ayaka Umeda, Shota Suzuki, Kaho Egawa, Kosuke Nishinaka, Daisuke Okuzaki iD, Shota Tanaka, Junichi Sadoshima, So-Ichiro Fukada, Yoshiaki Okada, Yasushi Fujio iD

Cardiovascular Research · 2026

DOI: 10.1093/cvr/cvag151 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, 2026. Verfasst von Yusuke Kametani und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Clinical Science and Biomedicine, Graduate School of Pharmaceutical Sciences, The University of Osaka, 1-6 Yamadaoka, Suita, Osaka 565-…. Hauptthemen laut MEDLINE: Myocarditis, Interferon-gamma, Myocytes, Cardiac, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: MEXT, JSPS KAKENHI, Grant-in-Aid for Japan Society for the Promotion of Science Research Fellowships for Young Scientists.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Despite the limited resilience of adult mammalian hearts, the heart damaged by inflammation naturally heals in a majority of patients with myocarditis. Therefore, therapeutic activation of intrinsic healing capacity of the heart would be promising as regenerative medicine. Yes-associated protein 1 (YAP) determines organ size by regulating cell proliferation. However, the physiological roles of YAP activation in adult mammalian cardiomyocytes remain unclear. This study aimed to investigate the role of endogenous YAP activation in cardiac remodelling during myocarditis to clarify the molecular mechanisms underlying myocardial recovery. Methods and results We demonstrate that YAP, which is activated in human cardiomyocytes during the myocardial remodelling after acute myocarditis, plays critical roles in myocardial healing. To elucidate the underlying mechanisms, we utilized a murine experimental autoimmune myocarditis (EAM) model. In cardiomyocyte-specific Yap1-conditional knockout (YAPCKO) mice, myocardial recovery is impaired after EAM with increased apoptotic cell death, fibrosis and ROS production, and reduced cardiomyocyte cell–cycle activity and capillary density. RNA-sequencing analysis demonstrated that IFN-γ/STAT1 signalling is activated in YAPCKO cardiomyocytes in myocarditis. IFN-γ blockade and cardiac-specific STAT1 knockdown restore the above-mentioned adverse phenotypic changes in YAPCKO hearts. Furthermore, in cultured adult mouse cardiomyocytes, the activation of YAP by GA-017, a Lats inhibitor, attenuated IFN-γ signal transduction. Mechanistically, YAP activation suppresses STAT1 nuclear localization and reduces STAT1-mediated transcription.

Conclusion

Endogenous YAP acts as a negative regulator of IFN-γ/STAT1 signalling, promoting myocardial repair after myocarditis. Our findings presented here provide novel insights into the molecular regulation of myocardial healing, proposing a novel therapeutic strategy for patients with heart failure after myocarditis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MyocarditisInterferon-gammaMyocytes, CardiacAdaptor Proteins, Signal TransducingCell Cycle ProteinsAutoimmune DiseasesVentricular RemodelingAnimalsSignal TransductionSTAT1 Transcription FactorYAP-Signaling ProteinsDisease Models, AnimalHumansRecovery of FunctionMice, KnockoutApoptosisFibrosisMice, Inbred C57BLCells, CulturedMaleCell Proliferation

Stichwörter der Autor:innen

IFN-γ signalingMyocardial recoveryMyocarditisYAP

Substanzen

STAT1 Transcription FactorInterferon-gammaYAP-Signaling ProteinsYap1 protein, mouseStat1 protein, mouseAdaptor Proteins, Signal TransducingCell Cycle ProteinsYAP1 protein, humanIFNG protein, mouseSTAT1 protein, human

Autor:innen und Institutionen

  • Laboratory of Clinical Science and Biomedicine, Graduate School of Pharmaceutical Sciences, The University of Osaka, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan.
  • Institute for Open and Transdisciplinary Research Initiatives, The University of Osaka, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan.
  • Global Center for Medical Engineering and Informatics, The University of Osaka, Osaka, Japan.
  • Radioisotope Research Center, Institute for Radiation Sciences, The University of Osaka, Osaka, Japan.
  • Genome Information Research Center, Research Institute for Microbial Diseases, The University of Osaka, Osaka, Japan.
  • Department of Cell Biology and Molecular Medicine, New Jersey Medical School, Rutgers University, Newark, New Jersey, USA.

ORCID-Profile: Daisuke Okuzaki, Yasushi Fujio

Förderung

  • MEXT
  • JSPS KAKENHI
  • Grant-in-Aid for Japan Society for the Promotion of Science Research Fellowships for Young Scientists
  • NHLBI NIH HHS
  • Platform Project for Supporting Drug Discovery and Life Science Research
  • Hyogo Science and Technology Association
  • NIH

Zitieren

APA

Kametani, Y., Obana, M., Umeda, A., Suzuki, S., Egawa, K., Nishinaka, K., Okuzaki, D., Tanaka, S., Sadoshima, J., Fukada, S. I., Okada, Y., & Fujio, Y. (2026). YAP plays a critical role in myocardial recovery from myocarditis by suppressing IFN-γ signalling pathway. Cardiovascular Research. https://doi.org/10.1093/cvr/cvag151

Vancouver

Kametani Y, Obana M, Umeda A, Suzuki S, Egawa K, Nishinaka K, et al. YAP plays a critical role in myocardial recovery from myocarditis by suppressing IFN-γ signalling pathway. Cardiovascular Research. 2026. doi:10.1093/cvr/cvag151

BibTeX
@article{Kametani2026,
  author = {Kametani, Yusuke and Obana, Masanori and Umeda, Ayaka and Suzuki, Shota and Egawa, Kaho and Nishinaka, Kosuke and Okuzaki, Daisuke and Tanaka, Shota and Sadoshima, Junichi and Fukada, So-Ichiro and Okada, Yoshiaki and Fujio, Yasushi},
  title = {YAP plays a critical role in myocardial recovery from myocarditis by suppressing IFN-γ signalling pathway},
  journal = {Cardiovascular Research},
  year = {2026},
  doi = {10.1093/cvr/cvag151}
}
Kostenlos starten →